According to Goldstein Research, a significant upsurge in automation, higher penetration of insurance cover, rapid urbanization, increasing number of laboratories, mounting consolidation, health awareness, and improvement in medical infrastructure are the major factors responsible for the growth. Moreover, the government is also increasing public expenditure on healthcare from just 1% to 2.5% of GDP. India In-Vitro diagnostics market report also includes new business models, product developments and capital investment as the key strategies adopted by the major players for a significant expansion of business in the country. The molecular diagnostics products market is growing swiftly as they possess higher accuracy and allow for quick detection of infectious diseases and genetic disorders at an initial stage of development. However, lack of proper reimbursement system around the globe is the major concern for the in-vitro diagnostics market.
Market Segmentation
On the basis of our in-depth analysis, India In-Vitro diagnostics market can be segmented and sub-segmented as:
- Based on Healthcare Segments
- By Immunochemistry
- By-Products
- Chemiluminescence immunoassay (CLIA) analyzers
- ImmunoFluorescence (IFA) analyzers
- Enzyme immunoassay (EIA) analyzers
- Integrated analyzers
- Point of Care Testing (POCT) Devices (benchtop and handheld)
- By Reagents (thyroid, infectious disease, fertility hormones, tumor marker, auto-immune kits, cardiac markers, others)
- By Services
- By-Products
- By Clinical Chemistry
- By-Products (Clinical Chemistry Analyzers)
- By Reagents (calibrators, controls, standards, other reagents)
- By Services
- By Hematology
- By-Products
- Semi-automated hematology analyzers
- Fully automated hematology analyzers
- POCT Devices (benchtop and handheld)
- By Reagents (coagulation reagents, flow cytometer reagents, hematology reagents, control plasmas, hematology stains, immunohematology reagents)
- By Services
- By Coagulation & Hemostasis
- By-Products (fully automated and semi-automated)
- By Reagents (prothrombin time (PT), activated partial thromboplastin time (aPTT), factor assays, fibrinogen, fibrinolysis, thrombin time (TT), thrombophilic profile, specialty assays)
- By Services
- By Clinical Microbiology
- By-Products (microbiology analyzers)
- By Reagents (pathogen-specific kits and general reagents)
- By Services
- By Molecular Diagnostics
- By-Products (PCR, DNA sequencing, flow cytometry, mass spectrometry, others)
- By Reagents
- By Services
- By Biochemistry
- By Product (Automated and semi-automated)
- By Reagents
- By Services
- Others
- By Product
- By Reagents
- By Services
- Based on Application
- Oncology
- Diabetes
- Infectious Disease
- Cardiology
- Autoimmune Disease
- Nephrology
- Drug Testing
- Others
- Based on End User
- Hospitals
- Diagnostics/Pathology Labs
- Research and Development Centers (R&D)
- Home care Settings
Download Exclusive Sample Report: https://www.goldsteinresearch.com/request-sample/india-in-vitro-diagnostics-ivd-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024
“India In-Vitro-Diagnostics Market Outlook 2024” contains a detailed overview of the India In-Vitro-Diagnostics market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by the display, by resolution, by screen size, by distribution channel, and by end users.
Further, for the in-depth analysis, In-Vitro-Diagnostics Industry Analysis encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such as Roche Diagnostics, Beckman Coulter, Siemens, Transasia Bio-Medicals Ltd., Accurex, Bayer Healthcare, Becton and Dickinson and bioMerieux etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services, and industries catered, financial analysis of the company and recent developments.
Overall, the report represents the India In-Vitro-Diagnostics market trends along with a market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.
About Goldstein Research
Based in the US, Goldstein Research, a market research & analysis firm currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts, working on healthcare industry reports helping various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.
Media Contact
Company Name: Goldstein Research
Contact Person: Steve Blade
Email: Send Email
Phone: +1-6465687747
Address:99 Wall Street, Suite No:- 527
City: New York
State: NY
Country: United States
Website: http://www.goldsteinresearch.com/